Collagen Gene Variants and Anterior Cruciate Ligament Rupture in the Korean Population

Article information

Exerc Sci. 2024;33(4):409-414
Publication date (electronic) : 2024 November 30
doi : https://doi.org/10.15857/ksep.2024.00542
1Department of Kinesiology, Inha University, Incheon, Korea
2Department of Sports Science, Korea Institute of Sports Science, Seoul, Korea
3Department of Orthopaedic Surgery, College of Medicine, Gachon University, Incheon, Korea
4Department of Biomedical Science, Program in Biomedical Science and Engineering, Inha University, Incheon, Korea
Corresponding author: Dong-Ho Park Tel +82-32-860-8182 Fax +82-32-860-8188 E-mail dparkosu@inha.ac.kr
†Ki-Hoon Seong and Eunwook Chang contributed equally as first authors.
*The study was funded by y the National Research Foundation of the Republic of Korea (NRF-2020R1F1A066854).
Received 2024 October 16; Revised 2024 November 14; Accepted 2024 November 30.

Abstract

PURPOSE

Anterior cruciate ligament rupture (ACLR) is a common knee ligament injury that occurs in sports. The precise etiology of ACLR remains unknown. Previous studies in various ethnic groups have confirmed an association between genetic variants and ACLR; however, no such research has been conducted in Koreans. This study aimed to investigate whether certain single nucleotide polymorphisms (SNPs), namely COL3A1 rs1800255, COL5A1 rs12722, COL12A1 rs970547, and COL5A1 rs13946, are associated with ACLR in the Korean population.

METHODS

This study involved 60 ACLR patients (ACL group, average age 29.9±10.9 years) and 328 control subjects (CON group, average age 23.8±4.1 years). All the participants were genotyped for COL3A1 rs1800255, COL5A1 rs12722, COL12A1 rs970547, and COL5A1 rs13946.

RESULTS

No significant genotypic differences were found for COL3A1 rs1800255 (p=.565), COL5A1 rs12722 (p=.779), COL12A1 rs970547 (p=.193), or COL5A1 rs13946 (p=.356). Furthermore, no significant differences were observed between the homozygous and dominant models for each SNP or between the haplotypes of COL5A1 rs12722 and rs13946 (p=.118). However, a significant association with ACLR was observed for the genotype combinations COL3A1 rs1800255 and COL5A1 rs12722 (p=.02).

CONCLUSIONS

The results of this study indicate that specific genotypes (SNPs) COL3A1 rs1800255 and COL5A1 rs12722 may influence the occurrence of ACLR. Considering the results and limitations of this study, future research should focus on increasing the sample size, particularly by including both male and female patients of diverse ages, to further validate these findings.

INTRODUCTION

Anterior cruciate ligament (ACL) tears are common knee ligament injuries that occur frequently during sports activities [1-3]. The precise etiology of ACLR remains unknown. Numerous external and internal risk factors, including genetic factors, have been identified. If a parent or sibling has experienced an ACL tear, the risk of ACLR appears to more than double [4,5].

The ACL, one of the four major ligaments in the knee, is defined as the collagen tissue that spans the joint and is anchored to the bones at both ends [6]. Ligaments are composed of fibroblasts surrounded by a cellular matrix; the fibroblasts play a role in matrix synthesis and constitute a small proportion of the ligaments overall. Ligaments and tendons assist in connecting forces and facilitating joint strength in the musculoskeletal system [7]. The primary component of the ligaments is collagen, with Type I collagen accounting for 85% of the total collagen— the remaining 15% consists of Types III, VI, V, XI, and XIV collagens [8]. Collagen represents 75% of the dry weight of the ACL, with the remaining weight comprising proteoglycans, elastin, various proteins, and glyco-proteins [6]. The genes COL3A1 and COL5A1 encode the α1 chains of Type III and V collagens, respectively, and polymorphisms within these genes have been identified in several studies as associated with the risk of ACLR [9,10].

A study by Stepien-Slodkowska et al. [11], in which Polish recreational skiers were the study population, demonstrated an association between the COL3A1 rs1800255 polymorphism and ACLR. Skiers with the AA genotype were found to have an almost five-fold higher probability of ACL injury than those with the AG+GG genotype. In a study by Posthumus et al. [10] investigating COL5A1 rs12722(T/C) and COL12A1 rs970547(A/G) single nucleotide polymorphisms (SNPs) in relation to ACLR, the group of 216 study participants included 129 females clinically diagnosed with ACLR (including 38 females with the AA genotype of COL12A1) and 83 females with no history of ACL injury. The results of the study revealed a statically significant correlation of the COL12A1 SNP— with a high frequency of the AA genotype— with ACL injury risk only in females (p =.048) and not in males (p =.359). In addition, in a study by Zhao et al. [12] involving 101 Han Chinese individuals with ACL injuries, no significant differences in ACLR risk were found in study subjects with COL5A1 rs12722 or rs13946. However, the A allele and AA genotype of COL12A1 rs970547 in males were associated with a higher risk of ACL injury. When examining these previous results, it becomes evident that differences may exist not only with regard to race, but also sex (male/female). Recently published studies have explored ACLR in diverse racial populations; however, studies targeting the Korean population are currently lacking.

Accordingly, the objective of this study was to investigate— in a Korean study population— the possible association between ACLR and the SNPs COL3A1 rs1800255, COL5A1 rs12722, COL12A1 rs970547, and COL5A1 rs13946, which have been previously suggested to be related to ACLR.

METHODS

1. Participants

The clinical study followed the Declaration of Helsinki. The Institutional Review Board and Ethical Committee of Inha University (Incheon, Korea) approved the study (approval no. 2000824-6A).

This study was conducted with a group of Koreans, including individuals diagnosed with ACLR (“ ACL” group, n=60) and a control group (“ CON” group, n=328) with no history of ACLR. In the ACL group, 55 patients underwent ACLR surgery and the other 5 did not. All participants were recruited from local hospitals, sports centers, universities, and similar institutions. An identical sample size between the two groups could increase statistical power; however, there were limitations in recruiting patients diagnosed with ACL injuries. Additionally, 143 was determined to be the total sample size needed to investigate the frequency difference of each SNP's genotype between the two groups, with an effect size of 0.3, a power of 0.8, and an α level set below 0.05. The purpose and content of the study were explained to all the participants, and their consent was obtained before conducting the research. The characteristics of the participants are presented in Table 1.

Characteristics of the participants

2. Body measurements and family history

Height, weight, body fat percentage, and body mass index (BMI) were measured to assess body composition. Height and weight were measured using a TBF-2002 measurement device (Tantia Co., Japan), with the participants wearing short sleeves and shorts. Weight was measured with an accuracy of 0.01 kg, and height was measured with an accuracy of 0.1 cm. The BMI of each participant was calculated as weight (kg) divided by the square of height (m). Family histories were assessed through a questionnaire.

3. DNA extraction and SNP genotyping

Approximately 200 µL of whole blood was collected from the individual's fingertips using a capillary tube (HCH-41B2501, Kimble Chase, USA). Genomic DNA was extracted using the AccuPrep Genomic DNA Extraction Kit (K-3032, Bioneer, Korea), following the manufacturer's instructions. The DNA was quantified using a NanoDrop 1000 spectro-photometer (Thermo Fisher Scientific, USA). COL3A1 (rs1800255), CO-L5A1 (rs12722), and COL12A1 (rs970547) were analyzed using a SNaP-shot® Multiplex System (Thermo Fisher Scientific) and COL5A1 (rs13946) was analyzed using a TaqMan SNP Genotyping Assay (Thermo Fisher Scientific).

4. Statistical analysis

All statistical analyses were conducted using IBM SPSS Statistics for Windows version 25.0. The characteristics of the participants between the two groups were presented as means and standard deviations.

Genotype and allele frequencies and distributions based on ACLR diagnosis were calculated for subjects diagnosed with ACLR and the general population. Depending on the sample size, either the chi-square test or Fisher's exact test was employed to examine the frequency differences in genotypes and alleles between the two groups (ACL group and CON group). The reason is that the χ2 test is appropriate when all expected frequencies in the cells are 5 or greater, whereas Fisher's exact test is used when any expected frequency is less than 5. The statistical significance level was set at less than 5% (p <.05).

RESULTS

1. Genotype and allele frequencies

Differences between the ACL and CON groups in terms of the frequency distributions of the studied SNPs— COL3A1 rs1800255, COL5A1 rs12722, COL12A1 rs970547, and COL5A1 rs13946— are shown in Table 2. The frequency distributions of alleles and genotypes did not show any significant differences between the ACL and CON groups (Table 2).

Genotypic and allelic frequencies of the CON and ACL groups

2. Homozygous and dominant genotypes

In the statistical results for Homozygous and Dominant models of COL3A1 rs1800255, COL5A1 rs12722, COL12A1 rs970547, and COL5A1 rs13946, there was no significant difference in genotypes between the two groups, as shown in Table 3.

Genotype frequency analysis based on genetic models between control and ACL groups

3. Genotype and allele frequencies

There was no significant difference in haplotype analysis between rs12722 and rs13946 of COL5A1 (Table 4).

Haplogenotype frequencies of rs12722 and rs13946 in the COL5A1 gene between Control and ACL Groups

4. Genotype and allele frequencies

In the group targeted for COL3A1 rs1800255 and COL5A1 rs12722, significant differences were observed only in the AA and TT groups (p<.02). No significant differences were observed between COL3A1 rs1800255 and COL12A1 rs970547, COL3A1 rs1800255 and COL5A1 rs13946, CO-L5A1 rs12722 and COL12A1 rs970547, or COL12A1 rs970547 and CO-L5A1 rs13946 (Table 5).

Gene-gene interaction analysis of genotypic frequency between control and ACL groups

DISCUSSION

ACLR is commonly known as one of the most frequently occurring injuries in athletes [13]. If left untreated in the early stages, ACLR can lead to persistent instability of the knee, recurrent injuries, and serious consequences, such as removal of the intraarticular cartilage. Following ACL injury, the incidence of osteoarthritis can reach 80%, with early-on-set arthritis occurring mostly in patients aged between 30 and 50 years. This results in knee pain and reduced quality of life [14,15].

In this study, the association between ACLR and each of the selected SNPs, namely COL3A1 rs1800255, COL5A1 rs12722, COL12A1 rs970547, and COL5A1 rs13946, was examined. The results showed that the individual genotypes or alternative alleles of these genes did not exhibit significant differences in ACLR. However, the results of the gene-gene interaction analysis, the COL3A1 rs1800255 and COL5A1 rs12722 AA-TT genotypes showed a significant difference between the ACLR group and the control group. These findings suggest that, in the context of the Korean population, the interaction between genotypes may have a more significant impact on ACLR than individual genotypes.

In previous studies conducted in different populations, 321 male Polish recreational skiers (138 ACL group vs. 183 control group) showed an association between the COL3A1(rs1800255) AA genotype and ACLR [16]. The COL3A1 (rs1800255) AA genotype, on the other hand, did not significantly associated with ACLR in a research involving 108 professional men's football players (45 ACL group vs. 63 control group) of the same ethnicity. Additionally, a study [17] examining the relationship between COL5A1 polymorphisms and ACLR in Australian (362 ACL group vs. 80 control group), South African (235 ACL group vs. 232 control group), and Japanese individuals (500 ACL group vs. 1403 control group) found that the CC genotype was only associated with ACLR in the Japanese population. In contrast, Chinese individuals (101 ACL group vs. 110 control group) demonstrated an association between the COL12A1 rs970547 genotype and ACLR, whereas the COL5A1 rs12722 and rs13946 genotypes were not related to ACLR [12]. Italian individuals (86 ACL group vs. 96 control group) did not show any association between the COL5A1 rs13946 and COL12A1 rs970547 genotypes or ACLR [18]. These diverse results suggest the importance of race and region, as different outcomes have been observed based on ethnicity or residence [13,17,19]. Furthermore, the statistical power is greatly impacted by the sample size of the ACL group because the distribution of genotypes for each SNP is not equal. Thus, it is crucial to secure above 100 samples. This study differs from earlier research in that it identified substantial differences only in gene-gene interactions, but no differences in the frequency distribution of genotypes for each SNP linked to ACLR. This result may be due to the relatively small individual effects of the SNPs associated with ACLR examined in this study, which manifested as gene-gene interaction effects with vulnerable genotypes between genes. Alternatively, the reduced statistical power resulting from the small sample size mentioned earlier could also have contributed to this outcome.

A family history of ACLR has been reported in some studies, suggesting the possibility of genetic factors influencing knee injuries and other musculoskeletal tissue damages [20,21]. Genetic factors are also reported to influence injuries to the Achilles tendon and shoulder rotator cuff [20]. Female twins were shown to have several functional factors that increase the risk of ACLR, including an increased intraarticular knee angle, decreased knee flexion angle, and increased overall joint laxity, all of which increase the likelihood of ACLR [20]. Recently, Magnusson et al. [22] investigated the heritability and family risk of ACL rupture in 88,414 identical and fraternal twins at least 17 years old. ACL rupture had a high overall heritability of 69%, rising from 60% at age 17 to 80% at age 60. The heritability and familial risk of ACL rupture were comparable for men and women. These findings contradict previous studies [10,12,20] that indicate sex-specific genetic variations in ACLR. Despite the high genetic influence, the ACL group in this study showed a family history similar to the Con group, which presents a result contrary to that of Magnusson et al. [22]. The primary causes of this discrepancy might be that our study is cross-sectional rather than longitudinal like Magnusson et al.’ s, it isn’ t a twin study that could evaluate genetic influence, the participants are young, and the sample size is relatively small. Especially, the age of onset may be later even if there is a genetic vulnerability, which could explain the variations from these previous studies [10,12,20-22].

This examination of the association between ACLR and Koreans yielded results that differ from those of previous studies conducted in different ethnicities. This discrepancy can be attributed to differences in study populations. However, one major limitation of this study is the small sample size, which can reduce statistical power when subdivided into specific subgroups. Furthermore, it was difficult to examine gender differences in this study due to the small number of female ACLR patients. Considering the results and limitations of this study, future research should focus on increasing the sample size, particularly in diverse age groups (20-30s and 50-60s) and both sexes (male and female), to further validate these findings.

CONCLUSION

In this study, individuals of Korean descent in their 20s and 30s with the AA genotype of COL3A1 rs1800255 and the TT genotype of CO-L5A1 rs12722 were found to be more susceptible to ACLR. These results suggest that the association between genetic diversity and ACLR may vary depending on the race and region. The causes of ACLR may involve not only genetic factors, but also various environmental factors and life-style patterns, leading to diverse outcomes.

Notes

The authors declare that they have no competing interests.

AUTHOR CONTRIBUTIONS

Conceptualization: KH Seong, E Chang, KJ Kim, BH Lee; Data curation: KH Seong, E Chang, HJ Park, KJ Kim, BH Lee; Methodology: HJ Park; Writing - original draft: KH Seong; Writing - review & editing: E Chang.

References

1. . Frobell RB, Roos EM, Roos HP, Ranstam J, Lohmander LS. A randomized trial of treatment for acute anterior cruciate ligament tears. N Engl J Med 2010;363(4):331–42.
2. . Meuffels DE, Verhaar JA. Anterior cruciate ligament injury in professional dancers. Acta Orthop 2008;79(4):515–8.
3. . Toth A, Cordasco F. Anterior cruciate ligament injuries in the female athlete. J Gend Specif Med 2001;4(4):25–34.
4. . Flynn RK, Pedersen CL, Birmingham TB, Kirkley A, Jackowski D, et al. The familial predisposition toward tearing the anterior cruciate ligament: a case control study. Am J Sports Med 2005;33(1):23–8.
5. . John R, Dhillon MS, Sharma S, Prabhakar S, Bhandari M. Is there a genetic predisposition to anterior cruciate ligament tear? A systematic review. Am J Sports Med 2016;44(12):3262–9.
6. . Frank CB. Ligament structure, physiology and function. J Musculo-skelet Neuronal Interact 2004;4(2):199.
7. . Hsu SL, Liang R, Woo SL. Functional tissue engineering of ligament healing. Sports Med Arthrosc Rehabil Ther Technol 2010;2:1–10.
8. . Szumiło P. A review of studies about the genes encoding the collagen proteins in the context of the anterior cruciate ligament rupture. Cent Eur J Sport Sci Med 2014;5:91–7.
9. . Khoschnau S, Melhus H, Jacobson A, Rahme H, Bengtsson H, et al. Type I collagen α1 Sp1 polymorphism and the risk of cruciate ligament ruptures or shoulder dislocations. Am J Sports Med 2008;36(12):2432–6.
10. . Posthumus M, September AV, Keegan M, O'Cuinneagain D, Van der Merwe W, et al. Genetic risk factors for anterior cruciate ligament ruptures: COL1A1 gene variant. Br J Sports Med 2009;43(5):352–6.
11. . Stępień-Słodkowska M, Ficek K, Eider J, Leońska-Duniec A, Macie-jewska-Karłowska A, et al. The+ 1245g/t polymorphisms in the collagen type I alpha 1 (col1a1) gene in polish skiers with anterior cruciate ligament injury. Biol Sport 2013;30(1):57–60.
12. . Zhao D, Zhang Q, Lu Q, Hong C, Luo T, et al. Correlations between the genetic variations in the COL1A1, COL5A1, COL12A1, and β- fibrinogen genes and anterior cruciate ligament injury in Chinese patientsa. J Athl Train 2020;55(5):515–21.
13. . Kaynak M, Nijman F, van Meurs J, Reijman M, Meuffels DE. Genetic variants and anterior cruciate ligament rupture: a systematic review. Sports Med 2017;47:1637–50.
14. . Gelber AC, Hochberg MC, Mead LA, Wang NY, Wigley FM, et al. Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann Intern Med 2000;133(5):321–8.
15. . Wilder F, Hall B, Barrett J Jr, Lemrow N. History of acute knee injury and osteoarthritis of the knee: a prospective epidemiological assessment. The Clearwater Osteoarthritis Study. Osteoarthritis Cartilage 2002;10(8):611–6.
16. . Stępień-Słodkowska M, Ficek K, Maciejewska-Karłowska A, Sawczuk M, Ziętek P, et al. Overrepresentation of the COL3A1 AA genotype in Polish skiers with anterior cruciate ligament injury. Biol Sport 2015;32(2):143–7.
17. . Alvarez-Romero J, Laguette MJN, Seale K, Jacques M, Voisin S, et al. Genetic variants within the COL5A1 gene are associated with ligament injuries in physically active populations from Australia, South Africa, and Japan. Eur J Sport Sci 2023;23(2):284–93.
18. . Massidda M, Flore L, Scorcu M, Monteleone G, Tiloca A, et al. Collagen gene variants and anterior cruciate ligament rupture in Italian athletes: a preliminary report. Genes 2023;14(7):1418.
19. . Fang CJ, Miller JA, Yergensen CJ, Hall M Jr, Kanhere AP, et al. Racial/Ethnic disparities exist among patients who undergo anterior cruciate ligament reconstruction in socioeconomic status, perception of health status and literacy. Arthroscopy 2024. 101000.
20. . Hewett TE. Prevention of noncontact ACL injuries in women: use of the core of evidence to clip the wings of a “black swan”. Curr Sports Med Rep 2009;8(5):219–21.
21. . September AV, Cook J, Handley CJ, van der Merwe L, Schwellnus MP, et al. Variants within the COL5A1 gene are associated with Achilles tendinopathy in two populations. Br J Sports Med 2009;43(5):357–65.
22. . Magnusson K, Turkiewicz A, Frobell R, Englund M. High genetic contribution to anterior cruciate ligament rupture: Heritability-69%. Br J Sports Med 2021;55(7):385–9.

Article information Continued

Table 1.

Characteristics of the participants

Parameter ACL (n=60) CON (n=328)
Sexa Male 50 (83.3) 190 (57.9)
Female 10 (16.7) 138 (42.1)
Age (yr)a 29.9±10.91 23.8±4.08
Height (cm)a 173.1±6.83 171.1±9.04
Weight (kg)a 74.8±13.2 67.9 ±12.8
BMI (kg/m2)a 24.9±3.49 23 ±2.94
Family historyb Yes 4 (6.67) 20 (6.12)
No 56 (93.33) 308 (93.88)

CON, Control group; ACL, Anterior cruciate ligament rupture group; BMI, body mass index.

a

Data are presented as mean and SD;

b

Data are shown in frequencies and percentages.

Table 2.

Genotypic and allelic frequencies of the CON and ACL groups

Group Allelic frequencies (%) p* Genotypic frequencies (%) p*
COL3A1 rs1800255 G A GG GA AA
CON (n=325) 506 (77.6) 146 (22.4) .428 204 (62.8) 97 (29.8) 24 (7.4) .565
ACL (n=59) 86 (72.9) 32 (27.1) 33 (55.9) 20 (33.9) 6 (10.2)
COL5A1 rs12722 C T CC CT TT
CON (n=327) 504 (76.8) 152 (23.2) .799 191 (58.4) 121 (37) 15 (4.6) .779
ACL (n=59) 93 (78.8) 25 (21.2) 37 (62.7) 19 (32.2) 3 (5.1)
COL12A1 rs970547 G A GG GA AA
CON (n=326) 206 (33) 438 (67) .583 31 (9.5) 153 (46.9) 142 (43.6) .193
ACL (n=59) 44 (36.7) 76 (63.3) 10 (16.9) 23 (39) 26 (44.1)
COL5A1 rs13946 T C TT CT CC
CON (n=306) 360 (58.8) 252 (41.2) .682 105 (34.3) 150 (49) 51 (16.7) .356
ACL (n=59) 74 (61.7) 46 (38.3) 25 (42.4) 23 (39) 11 (18.6)

CON, Control group; ACL, Anterior cruciate ligament rupture group.

*

Chi-square or Fisher's exact test. The level of significance (α) was set at 0.05.

Table 3.

Genotype frequency analysis based on genetic models between control and ACL groups

SNPs Group Recessive modela p* Dominant modela p*
COL3A1 rs1800255 GG+GA (%) AA (%) GG (%) GA+AA (%)
CON (n=325) 301 (92.6) 24 (7.4) .434 204 (62.8) 121 (37.2) .32
ACL (n=59) 53 (89.8) 6 (10.2) 33 (55.9) 26 (44.1)
COL5A1 rs12722 CC+CT (%) TT (%) CC (%) CT+TT (%)
CON (n=327) 312 (95.3) 15 (4.6) .745 191 (58.4) 136 (41.6) .536
ACL (n=59) 56 (94.9) 3 (5.1) 37 (62.7) 22 (37.3)
COL12A1 rs970547 GA+GG (%) AA (%) GG (%) GA+AA (%)
CON (n=326) 184 (56.4) 142 (43.6) .942 31 (9.5) 295 (90.5) .088
ACL (n=59) 33 (55.9) 26 (44.1) 10 (16.9) 49 (83.1)
COL5A1 rs13946 TT+CT (%) CC (%) TT (%) CT+CC (%)
CON (n=306) 255 (83.3) 51 (16.7) .711 105 (34.3) 201 (65.7) .237
ACL (n=59) 48 (81.4) 11 (18.6) 25 (42.4) 34 (57.6)

CON, Control group; ACL, Anterior cruciate ligament rupture group.

a

Data are shown in frequencies and percentages.

*

Chi-square or Fisher's exact test. The level of significance (α) was set at 0.05.

Table 4.

Haplogenotype frequencies of rs12722 and rs13946 in the COL5A1 gene between Control and ACL Groups

COL5A1 Haplotypes Frequency (%) p*
rs12722 rs13946 CON ACL
CC / TT 37 (12.1) 12 (20.3) .118
CT / CT 59 (19.3) 9 (15.3)
TT / CC 0 (0) 0 (0)

CON, Control group; ACL, Anterior cruciate ligament rupture group.

*

Fisher's exact test. The level of significance (α) was set at 0.05.

Table 5.

Gene-gene interaction analysis of genotypic frequency between control and ACL groups

SNP1 SNP2 CON ACL p*
COL3A1 rs1800255 COL5A1 rs12722
GG / CC 1 118 (36.4) 18 (30.5)
GA / CT 32 (9.9) 4 (6.8) 1.00
AA / TT 0 (0) 2 (3.4) .02
COL3A1 rs1800255 COL12A1 rs970547
GG / GG 18 (5.6) 4 (6.8)
GA / GA 50 (15.5) 11 (18.6) 1.00
AA / AA 10 (3.1) 2 (3.4) 1.00
COL3A1 rs1800255 COL5A1 rs13946
GG / TT 61 (20.1) 15 (25.4)
GA / CT 51 (16.8) 10 (16.9) .714
AA / CC 3 (1) 1 (1.7) .662
COL5A1 rs12722 COL12A1 rs970547
CC / GG 22 (6.8) 8 (13.6)
CT / GA 59 (18.2) 7 (11.9) .067
TT / AA 9 (2.8) 0 (0) .160
COL12A1 rs970547 COL5A1 rs13946
GG / TT 12 (3.9) 5 (8.5)
GA / CT 72 (23.6) 11 (18.6) .141
AA / CC 5 (8.5) 5 (8.5) .285

CON, Control group; ACL, Anterior cruciate ligament rupture group.

*

Fisher's exact test. The level of significance (α) was set at 0.05.